Company
Genomate
The right drug. The first time. Every time.
Also known as Genomate Health
- Legal name
- Genomate Health
Claim, correct or request removal
Record updated 29 September 2026
About
Personalize cancer treatments with artificial intelligence Defeat cancer in its own game! Case by Case! Genomate has developed a computational solution to find the right targeted therapy for every cancer patient based on the individual molecular profile of their tumor.
Funding snapshot
- Total raised
- $10.4MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $2M2025-03-05
Funding rounds
- Round, 2025
- $2M2025-03-05, SEC form D sold, 1 investor
- Round, 2023
- $2.6M2023-10-10, SEC form D sold, 4 investors
- Round, 2022
- $5.7M2022-10-28, SEC form D sold, 7 investors
Loading relationship preview